Paul M. Cinciripini, PhD, on Smoking Cessation in Patients With Cancer

2017 NCCN Annual Conference

Paul M. Cinciripini, PhD, of The University of Texas MD Anderson Cancer Center, discusses the oncologist’s role in addressing and documenting cancer patients’ smoking and cessation attempts as well as treatment advances.

Ruben A. Mesa, MD, on Myeloproliferative Neoplasms and Myelofibrosis: New Treatment Guidelines

Ruben A. Mesa, MD, of the Mayo Clinic Cance...

Pancreatic Cancer

Margaret A. Tempero, MD, on Pancreatic Cancer: Active Systemic Treatment

Margaret A. Tempero, MD, of the UCSF Helen ...

Lymphoma

Leo I. Gordon, MD, on Hodgkin Lymphoma: Management Strategies

Leo I. Gordon, MD, of the Robert H. Lurie C...

Gynecologic Cancers

ASCO Post

Christina S. Chu, MD, on HPV and Cervical/Vulvar Cancer

Christina S. Chu, MD, of Fox Chase Cancer C...

Sarcoma

Suzanne George, MD, on Soft-Tissue Sarcoma: Evolving Treatment

Suzanne George, MD, of Dana-Farber Cancer I...

Mar

Today In Oncology

Paul M. Cinciripini, PhD, on Smoking Cessation in Patients With Cancer

Related Videos

Ruben A. Mesa, MD, on Myeloproliferative Neoplasms and Myelofibrosis: New Treatment Guidelines

Margaret A. Tempero, MD, on Pancreatic Cancer: Active Systemic Treatment

Leo I. Gordon, MD, on Hodgkin Lymphoma: Management Strategies

Christina S. Chu, MD, on HPV and Cervical/Vulvar Cancer

Suzanne George, MD, on Soft-Tissue Sarcoma: Evolving Treatment

FDA Approves Lorlatinib for Metastatic ALK-Positive NSCLC

Pyrotinib/Capecitabine vs Lapatinib/Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With Trastuzumab

First-Line Cemiplimab-rwlc vs Platinum-Doublet Chemotherapy in Advanced NSCLC With PD-L1 Expression ≥ 50%

Enfortumab Vedotin-ejfv in Previously Treated Advanced Urothelial Carcinoma

The Impact of a Pandemic on Mentorship in Medicine